News
Aug, 2008
Affitech and Omeros collaborate for antibody discovery and development
Tuesday 19 Aug, 2008
BMP Sunstone receives SFDA approval to manufacture multivitamin granules
Monday 18 Aug, 2008
AstraZeneca partners with Singapore institutions to develop anti-cancer compounds
Sunday 17 Aug, 2008
FDA approval for XENAZINE(R) (Tetrabenazine) for patients with Chorea associated with Huntington's disease
Sunday 17 Aug, 2008
Morphotek®, inc. signs license agreement with NCI for the development of a monoclonal antibody to treat prostate cancer
Wednesday 13 Aug, 2008
The Multiple Myeloma Research Consortium (MMRC) announces initiation of four-drug combination study to treat newly diagnosed multiple Myeloma patients
Wednesday 13 Aug, 2008
Oxygen Biotherapeutics develops gel version of Oxycyte®
Tuesday 12 Aug, 2008
FDA appoints orphan drug status to STX-100
Tuesday 12 Aug, 2008
Carna Biosciences enters agreement with Caliper Life Sciences
Friday 8 Aug, 2008
Cipher Pharmaceuticals enters into agreement with Ranbaxy for CIP-ISOTRETINOIN
Wednesday 6 Aug, 2008
Nutra Pharma collaborates with Centers for disease control and prevention
Wednesday 6 Aug, 2008
Capricorn Pharma and Teva Pharmaceuticals enter agreement for KORKOAT technology
Tuesday 5 Aug, 2008
UBC and CogState Ltd. enter partnership for cognitive assessment in clinical trials
Tuesday 5 Aug, 2008
HCT and Exforge approved by US FDA for treatment of high blood pressure
Monday 4 Aug, 2008
Kowa Company, Ltd. acquires ProEthic Pharmaceuticals, Inc.
Monday 4 Aug, 2008
© 2008 Ochre Media. All rights reserved.